Novel TGFβ Inhibitors Ameliorate Oral Squamous Cell Carcinoma Progression and Improve the Antitumor Immune Response of Anti-PD-L1 Immunotherapy.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Nils Ludwig; Łukasz Wieteska; Cynthia S. Hinck; Saigopalakrishna S. Yerneni; Juliana Hofstatter Azambuja; Richard Bauer; Torsten E. Reichert; Andrew P. Hinck; Theresa L. Whiteside

Journal title: Mol Cancer Ther

Journal number: 1

Journal publisher: American Association for Cancer Research

Published year: 2021

DOI identifier: 10.1158/1535-7163.mct-20-0944

ISSN: 1535-7163